News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

No Sales Force Expansion for Eli Lilly and Company (LLY) as Focus Shifts to Grabbing a Bigger Slice of U.S.'s Diabetes Market



9/25/2013 7:24:59 AM

Eli Lilly is not expanding but others are hiring! Check it out! (Isn't it tempting?)



Eli Lilly & Co. (LLY) is counting on the quality of a diversified product portfolio over boosting its sales forces to grab a bigger slice of the $22 billion U.S. diabetes market, a difference in strategy to some of its rivals. “I don’t think the market is responsive today to putting more and more sales people focused on brands,” Enrique Conterno, president of Lilly Diabetes, said in an interview. “We start with the patient and think of all the therapies we could have for him” instead of “trying to force a brand” on both diabetics and physicians, he said.

Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)

Read at BusinessWeek


comments powered by Disqus
   
Diabetes

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES